Table 2 Number of incidences, percentage, CIR, ASR, and Cumulative Rates (per 100,000) among both genders for all ages by 10 primary cancer sites, Yemen, 2020
From: Cancer statistics in Yemen: incidence and mortality, in 2020
Site | Male | Site | Femal | Site | Both genders | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
N | % | Crude rate | ASR (World) per 100,000 | Cumulative risk (0–74) | N | % | Crude rate | ASR (World) per 100,000 | Cumulative risk (0–74) | N | % | Crude rate | ASR (World) per 100,000 | Cumulative risk (0–74) | |||
Colorectum | 790 | 11.0 | 5.3 | 12.0 | – | Breast | 2894 | 31.1 | 19.6 | 30.5 | 6.0 | Breast | 2894 | 17.6 | 19.5 | 30.5 | 6.0 |
Stomach | 546 | 7.6 | 3.6 | 8.9 | 3.8 | Colorectum | 722 | 7.7 | 4.9 | 9.5 | – | Colorectum | 1512 | 9.2 | 5.1 | 10.7 | – |
NHL | 526 | 7.3 | 3.5 | 5.0 | 0.93 | Oesophagus | 532 | 5.7 | 3.6 | 7.2 | 2.6 | Leukaemia | 988 | 6.0 | 3.3 | 4.2 | 0.66 |
Leukaemia | 514 | 7.2 | 3.4 | 4.4 | 0.67 | Leukaemia | 474 | 5.1 | 3.2 | 4.0 | 0.65 | Stomach | 966 | 5.9 | 3.2 | 7.1 | 2.7 |
BNS | 478 | 6.7 | 3.2 | 4.9 | 1.4 | Stomach | 420 | 4.5 | 2.8 | 5.7 | 1.9 | NHL | 862 | 5.2 | 2.9 | 4.0 | 0.63 |
Liver | 459 | 6.4 | 3.1 | 7.1 | 2.2 | Thyroid | 418 | 4.5 | 2.8 | 3.9 | 0.44 | Oesophagus | 859 | 5.2 | 2.9 | 6.4 | 2.3 |
Lung | 425 | 5.9 | 2.8 | 6.7 | 2.8 | Lung | 359 | 3.9 | 2.4 | 5.1 | 2.0 | BNS | 803 | 4.9 | 2.7 | 3.8 | 0.83 |
Oesophagus | 327 | 4.6 | 2.2 | 5.3 | 1.9 | NHL | 336 | 3.6 | 2.3 | 3.2 | 0.40 | Lung | 784 | 4.8 | 2.6 | 5.8 | 2.3 |
Larynx | 313 | 4.4 | 2.1 | 4.4 | 0.91 | Ovary | 329 | 3.5 | 2.2 | 3.4 | 0.46 | Liver | 745 | 4.5 | 2.5 | 5.1 | 1.5 |
Nasopharynx | 285 | 4.0 | 1.9 | 3.0 | 0.34 | BNS | 325 | 3.5 | 2.2 | 2.9 | 0.42 | Thyroid | 560 | 3.4 | 1.9 | 2.7 | 0.32 |
Other cancers | 2496 | 34.8 | – | – | – | Other cancers | 2508 | 26.9 | – | – | – | Other cancers | 5503 | 33.5 | – | – | – |